DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Liquid Biopsy Markets - Global Market Size, Strategies and Forecasts 2016 to 2020 including Screening Market Sizing" report to their offering.
A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology creates new markets for cancer screening tests.
GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening.
Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.
The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers.
Companies Mentioned Include:
- AdnaGen (now Qiagen)
- Agena Bioscience
- Angle plc
- Bio-Rad Laboratories
- Epic Sciences
- Exosome Diagnostics
- Exosome Sciences
- Fluidigm Corp
- Fluxion Biosciences
- GATC Biotech
- RainDance Technologies
- Rarecells SAS
- SRI International
- Sysmex Corporation
- Sysmex Inostics
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Liquid Biopsy Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
10. Potential Market Opportunity Sizes
For more information about this report visit http://www.researchandmarkets.com/research/sq27nv/liquid_biopsy